Shanghai Kinetic Medical Co., Ltd (300326.SZ)
CNY 6.83
(1.19%)
CNY 6.83
(1.19%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 140.07 Million CNY | 81561.82% |
| 2022 | 97.69 Thousand CNY | -99.96% |
| 2021 | 218.77 Million CNY | 350.91% |
| 2020 | -87.19 Million CNY | -124.27% |
| 2019 | 359.22 Million CNY | -27.81% |
| 2018 | 497.62 Million CNY | 114.66% |
| 2017 | 231.81 Million CNY | 28.41% |
| 2016 | 180.53 Million CNY | 7.96% |
| 2015 | 167.22 Million CNY | 125.39% |
| 2014 | 74.19 Million CNY | 15.34% |
| 2013 | 64.32 Million CNY | 25.57% |
| 2012 | 51.22 Million CNY | 20.94% |
| 2011 | 42.35 Million CNY | 33.4% |
| 2010 | 31.75 Million CNY | 64.15% |
| 2009 | 19.34 Million CNY | 68.46% |
| 2008 | 11.48 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 19.83 Million CNY | 176.97% |
| 2024 Q2 | 27.33 Million CNY | 37.83% |
| 2024 Q3 | 36.57 Million CNY | 33.78% |
| 2023 Q1 | 85.27 Million CNY | 138.17% |
| 2023 Q2 | 50.7 Million CNY | -40.54% |
| 2023 Q3 | 22.06 Million CNY | -56.48% |
| 2023 FY | 79.77 Million CNY | 81561.82% |
| 2023 Q4 | -25.76 Million CNY | -216.76% |
| 2022 Q4 | -223.42 Million CNY | -399.11% |
| 2022 FY | 97.69 Thousand CNY | -99.96% |
| 2022 Q3 | 74.69 Million CNY | 19.07% |
| 2022 Q1 | 86.09 Million CNY | 507.73% |
| 2022 Q2 | 62.73 Million CNY | -27.13% |
| 2021 Q1 | 61.26 Million CNY | 119.02% |
| 2021 FY | 218.77 Million CNY | 350.91% |
| 2021 Q2 | 73.78 Million CNY | 20.45% |
| 2021 Q4 | -21.11 Million CNY | -120.14% |
| 2021 Q3 | 104.84 Million CNY | 42.09% |
| 2020 Q2 | 79.97 Million CNY | 37.78% |
| 2020 Q1 | 58.05 Million CNY | -36.37% |
| 2020 Q4 | -322.13 Million CNY | -432.4% |
| 2020 Q3 | 96.91 Million CNY | 21.17% |
| 2020 FY | -87.19 Million CNY | -124.27% |
| 2019 Q2 | 96.06 Million CNY | 8.46% |
| 2019 FY | 359.22 Million CNY | -27.81% |
| 2019 Q3 | 83.35 Million CNY | -13.24% |
| 2019 Q1 | 88.57 Million CNY | -70.95% |
| 2019 Q4 | 91.22 Million CNY | 9.44% |
| 2018 Q1 | 56.43 Million CNY | 5.23% |
| 2018 Q4 | 304.93 Million CNY | 396.82% |
| 2018 Q3 | 61.37 Million CNY | -18.03% |
| 2018 Q2 | 74.87 Million CNY | 32.68% |
| 2018 FY | 497.62 Million CNY | 114.66% |
| 2017 Q1 | 45.97 Million CNY | 12.3% |
| 2017 FY | 231.81 Million CNY | 28.41% |
| 2017 Q2 | 68.84 Million CNY | 49.74% |
| 2017 Q4 | 53.63 Million CNY | -15.37% |
| 2017 Q3 | 63.37 Million CNY | -7.95% |
| 2016 FY | 180.53 Million CNY | 7.96% |
| 2016 Q1 | 33.15 Million CNY | -23.65% |
| 2016 Q2 | 43.81 Million CNY | 32.14% |
| 2016 Q3 | 62.62 Million CNY | 42.95% |
| 2016 Q4 | 40.93 Million CNY | -34.63% |
| 2015 Q3 | 32.48 Million CNY | 2.01% |
| 2015 Q4 | 43.42 Million CNY | 33.69% |
| 2015 FY | 167.22 Million CNY | 125.39% |
| 2015 Q2 | 31.84 Million CNY | -46.46% |
| 2015 Q1 | 59.47 Million CNY | 89.75% |
| 2014 Q3 | 12.89 Million CNY | 1.02% |
| 2014 Q2 | 12.76 Million CNY | -21.75% |
| 2014 Q1 | 16.3 Million CNY | -19.76% |
| 2014 FY | 74.19 Million CNY | 15.34% |
| 2014 Q4 | 31.34 Million CNY | 143.11% |
| 2013 Q2 | 17.68 Million CNY | 5.43% |
| 2013 FY | 64.32 Million CNY | 25.57% |
| 2013 Q3 | 9.53 Million CNY | -46.08% |
| 2013 Q4 | 20.32 Million CNY | 113.08% |
| 2013 Q1 | 16.77 Million CNY | 19.15% |
| 2012 Q3 | 8.09 Million CNY | -46.21% |
| 2012 Q2 | 15.04 Million CNY | 7.37% |
| 2012 Q4 | 14.08 Million CNY | 74.02% |
| 2012 Q1 | 14.01 Million CNY | -7.07% |
| 2012 FY | 51.22 Million CNY | 20.94% |
| 2011 Q1 | 8.44 Million CNY | 0.0% |
| 2011 Q4 | 15.07 Million CNY | 147.04% |
| 2011 Q3 | 6.1 Million CNY | -52.08% |
| 2011 Q2 | 12.73 Million CNY | 50.87% |
| 2011 FY | 42.35 Million CNY | 33.4% |
| 2010 FY | 31.75 Million CNY | 64.15% |
| 2009 FY | 19.34 Million CNY | 68.46% |
| 2008 FY | 11.48 Million CNY | 0.0% |